Provectus Biopharmaceuticals proposes rights offering

Provectus Biopharmaceuticals Inc. (NYSE-M:PVCT), Knoxville, Tenn. Business: Cancer, Autoimmune, Dermatology Date announced: 2016-10-05 Type: Rights offering To be raised: TBD Shares: TBD Price prior: ...